Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer. Li X, Mamouni K, Zhao R, Bai L, et al. Br J Cancer 2025 Apr 19. doi: 10.1038/s41416-025-02993.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Mamouni K, Zhao R, Bai L, et al. Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer. Br J Cancer 2025 Apr 19. doi: 10.1038/s41416-025-02993.
PMID: 40253488